Type 2 Diabetes Mellitus As Monotherapy Or In Combination With Metformin Or Pioglitazone (dual Therapy) Or In Combination With Both Metformin And A Sulfonylurea (triple Therapy) Or In Combination With Insulin (with Or Without Metformin) To Achieve Adequate Glycaemic Control:
Adult: 50 Mg Twice Daily
Type 2 Diabetes Mellitus In Combination With Sulfonylurea (if Metformin Inappropriate):
Adult: 50 Mg Daily, Dose To Be Taken In The Morning Dose Of Concomitant Sulfonylurea Or Insulin May Need To Be Reduced.
Children: Not Recommended.
Content
Tab 50mg: Vildagliptin 50mg.
Pregnancy
Contraindicated In Pregnancy.
Stability
Dipeptidyl Peptidase-4 Inhibitor
Contra Indications
Ketoacidosis, Severe Heart Failure, Severe Hepatic Impairment.
Precautions
Ketoacidosis, Severe Heart Failure, Severe Hepatic Impairment.
Lactation
Contraindicated or Not Recommended.
Side Effects
Peripheraloedema
Lactic Acidosis (discontinue)
Asthenia
Dizziness
Headache
Tremor
Arthralgia
Constipation
Hypoglycaemia
Rare: Hepatic Dysfunction
Upper Respiratory Tract Infection
Nasopharyngitis
Exfoliativeskin Reactions And Pancreatitis (discontinue).